EP3544569A1 - Fillable 3d flexible pouch for biopharmaceutical fluids, and method for producing such a pouch - Google Patents
Fillable 3d flexible pouch for biopharmaceutical fluids, and method for producing such a pouchInfo
- Publication number
- EP3544569A1 EP3544569A1 EP17822359.0A EP17822359A EP3544569A1 EP 3544569 A1 EP3544569 A1 EP 3544569A1 EP 17822359 A EP17822359 A EP 17822359A EP 3544569 A1 EP3544569 A1 EP 3544569A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- bellows
- wall element
- oblique
- flexible pouch
- welds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960000074 biopharmaceutical Drugs 0.000 title claims abstract description 32
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- 239000012530 fluid Substances 0.000 title description 18
- 238000005304 joining Methods 0.000 claims description 48
- 238000003466 welding Methods 0.000 claims description 32
- 239000000463 material Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- -1 polyethylene Polymers 0.000 claims description 11
- 239000004952 Polyamide Substances 0.000 claims description 9
- 229920002647 polyamide Polymers 0.000 claims description 9
- 239000004698 Polyethylene Substances 0.000 claims description 7
- 229920000573 polyethylene Polymers 0.000 claims description 7
- 229920003023 plastic Polymers 0.000 claims description 6
- 239000004033 plastic Substances 0.000 claims description 6
- 239000005038 ethylene vinyl acetate Substances 0.000 claims description 4
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 4
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 4
- 230000001419 dependent effect Effects 0.000 claims 1
- 239000010410 layer Substances 0.000 description 47
- 238000005520 cutting process Methods 0.000 description 13
- 238000003860 storage Methods 0.000 description 12
- 230000000670 limiting effect Effects 0.000 description 7
- 230000004888 barrier function Effects 0.000 description 5
- 239000003570 air Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 230000007704 transition Effects 0.000 description 4
- 239000000470 constituent Substances 0.000 description 3
- 229920000092 linear low density polyethylene Polymers 0.000 description 3
- 239000004707 linear low-density polyethylene Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 239000012080 ambient air Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000010836 blood and blood product Substances 0.000 description 2
- 229940125691 blood product Drugs 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- UFRKOOWSQGXVKV-UHFFFAOYSA-N ethene;ethenol Chemical compound C=C.OC=C UFRKOOWSQGXVKV-UHFFFAOYSA-N 0.000 description 1
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 1
- 238000005429 filling process Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000002346 layers by function Substances 0.000 description 1
- 229920004889 linear high-density polyethylene Polymers 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 238000013379 physicochemical characterization Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229910000679 solder Inorganic materials 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000009864 tensile test Methods 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
- B65B3/04—Methods of, or means for, filling the material into the containers or receptacles
- B65B3/045—Methods of, or means for, filling the material into the containers or receptacles for filling flexible containers having a filling and dispensing spout, e.g. containers of the "bag-in-box"-type
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D77/00—Packages formed by enclosing articles or materials in preformed containers, e.g. boxes, cartons, sacks or bags
- B65D77/04—Articles or materials enclosed in two or more containers disposed one within another
- B65D77/06—Liquids or semi-liquids or other materials or articles enclosed in flexible containers disposed within rigid containers
Definitions
- 3D flexible pouch to be filled for biopharmaceutical fluids, and method for making such a pouch
- the invention relates to the field of conditioning of biopharmaceutical fluids and more particularly relates to a flexible reservoir to be filled, in the form of a flexible bag 3D (three dimensions), which must generally be placed in a rigid container.
- the invention also relates to an equipment and a method for producing such a 3D flexible pouch.
- Biopharmaceutical product means a product derived from biotechnology, culture media, cell cultures, buffer solutions, artificial nutrition liquids, blood products and blood product derivatives, or a pharmaceutical product or more generally a product for use in the medical field. Such a product is in liquid form, pasty, or possibly powdery. The invention also applies to filling flexible bags with other products but subject to similar requirements with regard to their packaging.
- the volume is typically delimited by a lower end wall, a upper end wall and a flexible sidewall that can be in two extreme states - folded flat and unfolded unfolded.
- the 3D pocket may be deformed to move from one state to another or to any intermediate state.
- the walls of the pocket composed of a monolayer or multilayer film, of plastic material such as polyethylene or a complex comprising polyethylene, delimit an internal space which, in the folded state, is of minimum volume and, at the Unfolded and deployed state is maximum. This space is intended to receive the biopharmaceutical product for storage, processing, transport.
- Such a flexible pouch, biocompatible, disposable can define a large volume of 2 or 5 liters at least, up to 3000 liters, or even more, which justifies that it is called 3D.
- a pocket thus offers a large capacity while being easily stored.
- An example of such a pocket is described in the international application WO00 / 04131 or in the document FR 2781202.
- the welds at the top and the bottom of the pocket are made in K, before cutting the corner portions (cut to remove the outer parts of the films beyond the weld areas).
- the bag may also include sensors (temperature, pH, physico-chemical characterization of the biomass) and / or a treatment element, for example in the form of a mixer that can be operated by mechanical coupling or mobile by magnetic drive. .
- connection port or ports used in particular for filling or emptying, in a portion of the pocket that is separated from the weld areas.
- these connection ports are the only access to the internal space, the pockets being devoid of hinged or removable cover, flap opening / closing, peelable or tearable portion, and devoid of fragile areas. The pockets do not have areas of weakness in the weld areas.
- the bag is provided with a port for entering or introducing a biopharmaceutical product and a gas supply port, for example on the side of an upper end wall.
- Corresponding supply lines each connected to a power source (which is generally external to the rigid container for carrying and storing the filled 3D pocket), are connected to these respective ports.
- filling can be achieved by using a lower feed line.
- the document EP-B1 -0326730 describes a filling of this type, with the disadvantage that the flexible bag is more complex, it being provided with side flaps, which limits the interest of this type of option. It is generally desirable to limit the complexity and cost of the flexible pouch 3D which is a disposable consumable (this is the flexible pouch without any accessories).
- the K-weld also applies to medical or medicinal (single-use as well) pouches which have a large upper opening in a parallelepipedal expanded configuration, as described in particular in the patent. US 6332711 B1. In this case, it is preferable to provide a lower connection port for emptying.
- the invention relates to a flexible pouch 3D (bellows) for biopharmaceutical product, designed to deploy from a flat vacuum configuration to a substantially parallelepipedic configuration in a filled state.
- the flexible 3D pocket presents:
- first wall element consisting of a film and making it possible to define a front face, the first wall element having two lateral edges distributed on either side of a longitudinal axis of the pocket in the plane configuration,
- a second wall element consisting of a film and making it possible to define a rear face, the second wall element having two lateral edges distributed on either side of said longitudinal axis of the pocket in the plane configuration,
- first bellows and a second bellows each connected to two lateral edges of one and the other of the first and second wall elements, the first bellows and the second bellows consisting of respective films cut in one piece and each capable of folding, typically in two, along an inward fold line extending between two opposite ends of the flexible pouch,
- the flexible pouch has a junction portion that extends axially beyond a folded zone in two of the bellows and constitutes a reinforcing element that reduces the torsional stresses exerted in the wear zone.
- the two oblique edges meet at a free end of the joining portion and, in the planar configuration, these two oblique edges move away from each other away from the free end and are each extended, opposite the free end, at least rectilinearly by a section of the lateral edges which is welded to a longitudinal edge section of one of the first bellows and the second bellows.
- the two oblique edges are typically straight.
- This arrangement at one of the ends of the pocket makes it possible to define the first wall element and / or the second wall element by only two sides that are contiguous to the free end, unlike a K-weld that requires cutting. with three sides.
- the manufacturing method can be simplified, for example by making a V-cut and two corresponding welds, rather than two oblique cuts and a section perpendicular to the longitudinal axis to define three welding strips.
- the bag is provided with at least one connection port for filling and / or emptying, formed exclusively in one of the first wall member and the second wall member.
- the junction portion is typically flat and has, opposite a narrower free end, a wider, rectilinear base that extends transversely from one to the other of the fold lines of the first and second bellows.
- the junction portion may further remain flexible and bend, at least in the substantially parallelepipedic configuration, around a fold line defined by the rectilinear base and / or by conforming at C in a transverse sectional plane of the portion. junction.
- the two oblique edges are:
- the two fold lines are separated by a transverse spacing which is typically constant.
- the fold line of each bellows is straight and of a length at least 25 mm shorter than the maximum extension of the flexible bag measured along the longitudinal axis in the flat configuration.
- the junction portion is triangular, the respective lateral edges of one and the other of the first and second wall elements each having a rectilinear intermediate section extending between a first substantially straight section and a second section. , and being further adapted for:
- the first wall element and the second wall element have the same longitudinal dimension which is greater than a maximum longitudinal dimension respectively of the first bellows and the second bellows.
- the first wall element and the second wall element have the same hexagonal shape and essentially identical dimensions.
- the films constituting respectively the first wall element and the second wall element are welded to each other, to the other of the two opposite ends, so as to define an additional portion of junction of the lateral edges which protrudes axially outwardly with respect to the first and second bellows in the planar configuration.
- junction preferably triangular
- the first bellows and the second bellows are each in a folded state in two in the planar configuration, being bent inwards along a rectilinear fold line parallel to the longitudinal axis.
- connection port is placed in a flap defined by the first wall member, the junction portion side and with a spacing relative to junction portion.
- the flexible pouch comprises:
- first flaps one of which is part of the first wall element and the other part of the second wall element, the first two flaps being interconnected by the joining portion and forming, in combination with zones of the first and second bellows adjacent to the first two flaps, an outer face of the flexible pouch in the parallelepipedic configuration
- junction portion projecting from the outer face outwards in the parallelepiped configuration.
- two second flaps one of which is part of the first wall element and the other part of the second wall element, the two second flaps being interconnected by the additional connecting portion.
- the films which respectively constitute the first wall element, the second wall element, the first bellows and the second bellows are welded together by defining in the plane configuration:
- first continuous oblique welds which each extend from a given end of one of the side welds to the joining portion.
- the films which constitute respectively the first wall element, the second wall element, the first bellows and the second bellows are welded so as to further define in the plane configuration:
- each of the welds has a minimum width of at least 5 mm. This makes the pouch particularly robust and able to withstand severe transport constraints, in particular changes in external pressure (for example due to air transport).
- each of the films constituting respectively the first wall element, the second wall element, the first bellows and the second bellows present locally, along the welds, a thickness which is not less than the average thickness of said films, this average thickness being between 150 and 450 pm for each of these films.
- the free end of the joining portion defines an angle of between 60 and 100 °, preferably between 80 and 95 °, which corresponds to both:
- the films respectively constituting the first wall element, the second wall element, the first bellows and the second bellows:
- first bellows and. the second bellows each have a thickness of between 150 micrometers and 450 micrometers and a tensile strength of between 60 and 220 Newton.
- first bellows and. the second bellows each present:
- the maximum transverse extension of each of the first and second bellows is at least 15 cm between the first wall element and the second wall element; and the flexible pouch makes it possible to define an interior space at least equal to 2 L, preferably at least 5 L.
- a method for manufacturing a 3D flexible pouch according to the invention to be filled by a biopharmaceutical product in which process is carried out in a longitudinal scrolling direction:
- a first wall element provided with two lateral edges, consisting of a film and making it possible to define a front face
- a second wall element provided with two lateral edges, consisting of a film and making it possible to define a rear face
- first bellows and a second bellows each consisting of a film cut from one piece and delimited by two longitudinal edges
- each of the first bellows and the second bellows is inserted, in a folded state in two around a longitudinal fold line, between the first wall member and the second wall member, the first bellows and the second bellows being arranged with transverse spacing with respect to each other;
- the method further comprising the steps of:
- V-cut and the welds being made so that the pocket can be filled by a biopharmaceutical product in a parallelepipedic configuration of the flexible bag.
- the method thus advantageously makes it possible to minimize the number of cuts with respect to a K bond which has a transverse weld, made perpendicularly to the longitudinal axis of the pocket.
- the first wall element, the second wall element, the first bellows and the second bellows are defined by sheets having the same multilayer structure.
- the method may include an additional V-cut step to obtain a second tip axially opposite to the first tip.
- the second tip is typically also defined between the first virtual line coinciding with the longitudinal fold line of the first bellows and the second virtual line coinciding with the longitudinal fold line of the second bellows.
- a weld is made in an adjacent zone or in an area corresponding to the second point, in order to directly connect the first wall element directly to the second wall element (opposite the first point).
- Four second oblique welds similar to the first oblique welds, can be made to converge towards the second tip in the planar empty configuration.
- the transverse spacing between the first bellows and the second bellows makes it possible to form, between the fold lines, a determined line which defines a base of the joining portion, the deformation of these bellows making it possible to obtain a configuration parallelepipedic of the flexible bag in a filled state, parallelepipedic configuration in which the fold line of each of the bellows is U-shaped and tangentially joined to the determined line (tangential junction at one end of the fold line considered).
- connection port for connecting a flexible supply line.
- the V-cut is made at two opposite ends of the pocket, so that the first wall member and the second wall member have a hexagonal perimeter in the planar configuration, while the first bellows and the second bellows have a hexagonal perimeter in the planar configuration.
- FIGS. 1A and 1B are perspective views showing, in a first embodiment, a flexible bag 3D before filling with a biopharmaceutical fluid.
- FIG. 2 is a perspective view of the 3D flexible pouch of FIGS. 1A-1 B, in the deployed state and filled with a biopharmaceutical fluid.
- FIG. 3 shows a logic diagram of steps representing assembly steps and clipping of four constituent films of the flexible bag 3D.
- FIG. 4 schematically illustrates steps for obtaining two axial ends each delimited by two oblique edges.
- FIG. 5 is a sectional detail view illustrating an example of a welding step between a bellows and the adjacent wall elements of the 3D flexible bag.
- FIG. 6 is a cross-sectional view showing the arrangement of the four films on the base side of the triangular junction portion, in a preferred embodiment of the invention.
- FIG. 7 illustrates an example of a welding zone used for sealing in the triangular junction portion, between the first wall element and the second wall element.
- FIG. 8 is a side view showing the bottom of a 3D flexible pouch in the filled state and received in a storage device.
- FIG. 9 is a perspective view of a flexible 3D pocket with an arrangement of the connection ports in a central zone of a wall element, between two flaps of this wall element.
- - Figure 10 is a perspective view of a flexible bag 3D according to the prior art.
- - Figure 1 1 shows an example of composition of the constituent films of the flexible bag, according to the invention.
- the flexible pouch 1 which unfolds in three dimensions may have a planar configuration, in which two opposite wall elements 2, 3 define two opposite external main faces of the flexible pouch 1. It can be seen that this flexible pouch 1 has connection ports for filling and / or emptying.
- the connection port 4 may allow to connect, according to a non-limiting example, a flexible pipe 5 to perform a drain.
- this connection port 4 of the flexible pouch 1 of the 3D type extends in a first end face W1.
- one or more connectors 6 forming connection ports are provided here on the second end face W2 opposite the connection port 4, to allow filling of the flexible bag 1 (with typically several openings). entrance or supply).
- At least one flexible supply line is provided to fill the flexible pouch 3D via a connection port.
- the flexible pipes T1, T2 associated with the connectors 6 are of a kind known per se.
- the flexible sidewall W3 visible in FIG. 2 has predefined folds, in particular fold lines FL1 and FL2 formed in bellows January 1, 12 during the design of the flexible pouch 1, which facilitates correct unfolding as and as the fill level, typically by a biopharmaceutical fluid, rises.
- the position of the connection port or ports 4, 6 may vary, preferably by making the openings on one (preferably only one) of the wall elements 2 and 3.
- connection ports 4, 6 are placed remote from the connection areas between the two wall elements 2 and 3 and they do not interfere with the unfolding of the bellows January 1 and 12 of the flexible pouch 1 type 3D.
- the connection ports 4, 6 may be closed in a manner known per se (in the example of FIG. 10, the ports are sealingly connected to a length of tube or pipe T1, T2 itself closed off, in a sealed manner, by a clamp generally called “clamp” (C1, C2) by those skilled in the art, an aseptic connector, or may include valves or non-return valves or other similar systems of tight closure).
- FIG. 8 illustrates an example of application of the flexible pouch 1.
- the bottom defined by the first end face W1 is attached to the base portion B of a storage device 10, which can be used, if necessary, to carry the flexible pouch 1 type 3D in the filled state.
- the hose 5 to perform a drain is then able to pass through an orifice 05 located in the base portion B of the storage device 10. This cooperation with an orifice 05 makes it possible to position the first end face W1 of the flexible bag well.
- the flexible bag 1 can be placed in the interior volume of such a storage device 10 before a biopharmaceutical fluid filling step.
- the internal volume of the device 10 is accessible through an upper transverse opening, and possibly accessible using side doors.
- Figures 1 and 3 of WO 2015/1 18269 illustrate this type of storage device.
- the increase in volume of the flexible bag 1 can be done by minimizing the risk of formation of bad fold in the W1 face.
- the side wall W3 can also inflate without hindrance and without a bad fold to go from an extreme state (completely flat) to another extreme state (by defining a parallelepipedal volume), resting on the internal face of the storage device 10.
- This type of storage device 10 may be in the form of a rigid container, possibly with a possibility of stacking.
- connection port or ports 4, 6 can be placed exclusively in a flap 22 or two flaps 21, 22, defined by the first wall element 2 , optionally near a junction portion 25 by welding between the two wall elements 2 and 3 of the flexible bag 1 without crossing such a junction portion 25.
- This type of configuration is well suited in particular for placing the flexible bag 1 3D type in a storage device 10 without lateral access to the internal volume.
- each bellows 1 1, 12 caused by filling allows to separate the first wall element 2 of the second wall element 3 by a distance D at least equal to 12 or 15 cm , and preferably at least 40 or 50 cm for storage applications in the device 10. It is thus possible to contain, in such a flexible pouch type 3D, a volume of biopharmaceutical product of at least 2 liters, and preferably at least 5 liters.
- the distance D can correspond to a substantially constant spacing between the front face 2a defined by the first wall element 2 (face 2a located between the flaps 21 and 22) and the rear face defined by the second wall element 3 (face 3a located between the flaps 31 and 32).
- the first wall element 2 is typically a flexible piece consisting of a multilayer film and for defining a front face 2a of the flexible bag 1, while the second wall element 3, made in a similar or identical manner (by a multilayer film ) is a flexible piece for defining a rear face 3a of the flexible bag 1, as clearly visible in Figures 1A, 1B and 2.
- the bellows January 1 and 12 may have a material and a similar thickness (preferably identical) to what is provided for the wall elements 2 and 3. It is understood that the bellows 11 and 12 are constituted by respective films cut in one piece, the cutting can take place before, during or after the binding step with the wall elements 2 and 3.
- each of the films that make up the flexible pouch 1 is made of hot-swab plastic and biocompatible with transported media.
- each film has a multilayer structure. This multilayer structure can be broken down for example into three layers which are typically non-metallic plastic layers.
- the film may be transparent or translucent.
- first bellows 11 and the second bellows 12 each have:
- a heat-weldable inner layer forming the contact layer 16 a heat-weldable inner layer forming the contact layer 16; and a solderable outer layer of a material selected from polyethylene (preferably linear low density or optionally high linear density), polyamide, ethylene-vinyl acetate copolymer, polyamide, and ethylene polyethylene terephthalate.
- each of the films 102, 103, 1 1 1, 1 12 may have an assembly 17 of functional layers superimposed on a contact layer 16.
- an outer face made of PET can be provided by means of the outer layer 17c.
- This material which typically has a semi-crystallinity, gives good resistance to oxygen in the air (chemical resistance), low water absorption rate and thus allows long term storage applications.
- the thickness of the outer layer 17c may be particularly small, for example between 7 and 50 ⁇ m, preferably between 10 and 30 ⁇ m.
- the contact layer 16 (inner layer) is typically heat-weldable and may consist of a layer of material compatible with biological materials without deterioration effect.
- Polyethylene in particular linear low density polyethylene, is an example of a preferred material for constituting the contact layer 16, since it combines the advantages of compatibility with the biopharmaceutical fluid 7 and good weldability.
- Other materials with similar properties can be used, for example the ethylene-vinyl acetate copolymer.
- An intermediate layer 17a may correspond to the gas barrier layer (especially with respect to the oxygen and carbon dioxide present in the ambient air).
- one or two layers of tacky material may be provided on one side and / or the other of the barrier layer.
- Another intermediate layer 17b may consist of polyamide (PA), which improves the impact resistance (mechanical strength).
- PA polyamide
- the intermediate layer 17b for the mechanical strength is placed between the outer layer 17c and the layer 17a with a gas barrier effect. Due to the lower resistance of the gas barrier layer 17a, this can advantageously be placed between the contact layer 16 and the other layers 17b, 17c of the assembly 17.
- the composition of the multilayer film shown in FIG. Figure 1 1 can be used for all the films 02, 103, 1 1 1, 1 12 of the flexible bag 1 type 3D.
- Such a composition may make it possible to limit the thickness E to less than 450 ⁇ m, for example of the order of 200 or 400 +/- 50 ⁇ m.
- the thickness E may be reduced to approximately 100 +/- 30 ⁇ m, for example for applications without hermetic closure of the flexible bag 1.
- the layers 17b and 17c are replaced by a single layer of polyethylene, preferably linear low density polyethylene.
- polyethylene preferably linear low density polyethylene.
- the material of the contact layer 16 may also be linear low density polyethylene.
- the films preferably have three layers and have a tensile strength typically greater than 60 or 80 Newton. This tensile strength can generally be between 60 and 220 Newton. The flexible pouch 1 is thus particularly difficult to degrade.
- the elongation at break which defines the capacity of each of the films to elongate before breaking (in response to a tensile test), is for example greater than or equal to 80% but less than or equal to 400% or 500%. %. It is understood that the flexible pouch 1 has physical and mechanical properties well suited for the deployment of a folded state flat to a deployed parallelepiped state, which in practice eliminate the risk of accidental tearing.
- the first wall element 2 and the second wall element 3 may have a structure similar or identical to that of the bellows 11, 12.
- An intermediate layer for example having a barrier effect (for example based on EVOH or equivalent material ), can be provided in the multilayer structure of the elements 2, 3, 1, 1 defining the volume of the flexible pouch 1.
- the multilayer structure can be broken down into at least three non-metallic plastic layers, and is preferably transparent or translucent . Referring now to FIG. 1A, it will be noted that the bellows 11 and 12 are spaced from one another by a transverse spacing D2. This transverse spacing D2 corresponds to a typically constant distance.
- the fold lines FL1 and FL2 for the first bellows 11 and the second bellows 12 are then rectilinear and parallel to the lateral edges 8, 18 and 9, 19 defined by the wall elements 2 and 3. It can be seen that the lines Folding FL1 and FL2 extend on either side of the longitudinal axis A (in this case a central axis, as clearly visible in Figure 1 B) of the flexible bag 1 in the planar configuration.
- the first bellows January 1 is connected to two side edges 8 and 9 of the one and the other of the first and second wall elements 2 and 3.
- the second bellows 12 is connected to two other lateral edges 18 and 19 of one and the other of the first and second wall elements 2 and 3.
- the connection to the lateral edges 8, 18 of the first wall element 2 and at the lateral edges 9, 19 of the second wall element 2 results from a direct weld thus fixing the zones of the bellows 11 and 12 which border the lateral edges 8, 9, 18, 19. In what follows, these margin areas will be called longitudinal edges.
- the first bellows 11 and the second bellows 12 can each bend along their fold line FL1 and FL2, inwardly.
- the folding is performed in two equal halves for each bellows January 1, 12, at least in the planar configuration of the flexible bag 1.
- Each fold line FL1, FL2 extends between two opposite axial ends 14, 15 of the flexible pouch 1, as clearly visible in Figure 4 for example.
- the first four oblique welds SOI each extend from a determined end 34 of one of the lateral welds SL to the joining portion 25.
- the flexible pouch 1 may furthermore have four second oblique welds S02 which are extend each from the other end of a lateral weld SL.
- the joining portion 25, common to the four lateral edges 8, 9, 18, 19, here has a generally triangular shape and has a base which extends between a first intersection J1 where the lateral edges 8 and 9 joined to the first join. bellows 11 and a second intersection J2 where join the side edges 18 and 19 welded to the second bellows 12.
- the intersections J1 and J2 coincide with two vertices of the triangular shape presented by the joining portion 25.
- the portion junction 25 protrudes axially outwardly with respect to the first and second bellows January 1, 12. It is here delimited externally by two edges 25a, 25b, oblique with respect to the longitudinal axis A, which result from the cutting of respective side edges 8, 9, 18 and 19.
- the first wall element 2 and the second wall element 3 have the same general polygonal shape, here hexagonal, in the con flat figuration of the pocket 1.
- the lateral welds SL each extend between:
- each first oblique weld SOI deviates from the other first oblique welds in the parallelepipedic configuration until it reaches the determined end 34 of the lateral weld;
- this general shape may be pentagonal or heptagonal, while retaining the first four oblique welds SOI.
- the dimensions of the first wall member 2 and the second wall member 3 are substantially identical.
- the first bellows 11 and the second bellows 12 may also have identical dimensions in a preferred option.
- the first four oblique welds SO1 make it possible, for example, to define the oblique edges 25a, 25b of the joining portion 25.
- an additional joining portion 26 is formed by being also delimited by two edges obliques 26a, 26b, as clearly visible in Figure 1 B for example. From the intersections J1 and J2, the welds extend towards a free end of the joining portion 25, 26, despite the absence of a layer belonging to the bellows 11, 12.
- the weld in the joining portion or portions 25, 26 allows to connect the first wall element 2 to the second wall element 3 in a direct and sealed manner.
- the joining portion 25 is flat and has, opposite the narrower free end 25c, a base which is rectilinear and wider, which extends transversely of the one to the other of the fold lines FL1, FL2 of the first and second bellows January 1, 12.
- the two oblique edges 25a, 25 form an angle at the free end 25c.
- the two oblique edges 25a, 25b approach one another as we approach the free end 25c and are each extended, opposite the free end 25c, rectilinearly by sections of the lateral edges 8, 9, 18, 19. This results from the fact that the pocket is cut in V, defining the first four oblique welds SOI which are rectilinear in the planar configuration.
- the oblique edges 25a, 25b are not subjected to the effect of the deployment of the bellows 11, 12, out that they can be kept protruding relative to the second end face W2 which is formed by the folding of the rest of the first oblique welds SOI.
- Figure 6 illustrates a sectional detail of a flexible pouch 1 in planar configuration.
- This detail shows more particularly the central weld portion CB made directly between the inner faces of the wall elements 2 and 3 in the joining portion 25, here at a distance from the free end 25c (in a contact zone with the bellows 1 1, 12, separate from the portion which projects axially outwardly with respect to the bellows 1 1, 12).
- the configuration of the joining portion 25 covers the axial end 14 of the transition zones between the fold lines FL1 and FL2 and the central weld portion CB, which limits the risk of leakage.
- the layers defined by the first wall element 2 and the second wall element 3 are the only ones to define the oblique edges 25a, 25b, so that they cover the folded layers of the bellows January 1, 12 on the three sides exposed to the outside (these three sides are for example the front, the back and the top).
- the junction portion 25 of generally triangular shape, which axially covers the bellows January 1, 12 is absent in the conventional 3D soft bags (see Figure 10) which have a weld K (KS welds in the case of Figure 10).
- KS welds welds in the case of Figure 10.
- twists or other constraints mechanical means that would be sufficient to locally separate the bellows along intersections J1, J2 in the case of the pocket of Figure 10 can no longer be troublesome when a joining portion 25 is axially cover the transition zones of four layers to two layers.
- the weld or seams in the joining portion 25 have a protective effect on the more fragile transition zones, more precisely the zones formed at the folded narrow end of the bellows. This limits the risk of leakage.
- the junction portion 25, because of its flexibility, can slightly arch and bend forming a C-section, but better distributing the torsional stresses due to the axial extension of the central weld portion CB to the free end 25c.
- the inner faces of the first and second wall elements 2, 3 are preferably defined by a special heat sealable layer (inner side layer for contact with the biopharmaceutical fluid) of a multilayer structure.
- the central weld portion CB may be triangular, V-shaped with a rounded as shown in Figure 7 or without rounding.
- the maximum extension of the central weld portion CB (in the direction of elongation of the protruding band) may be equal to the transverse spacing D2 between the first bellows 11 and the second bellows 12 in the planar configuration.
- FIG. 4 illustrates the case of a cut made before obtaining the oblique welds SO1 and S02, it is also possible, as a variant, to delimit the ends 14 and 15 of the flexible pouch 1 posteriorly, the oblique edges 25a, 25b. , 26a, 26b being obtained in this case by a cutting step subsequent to the sealing of the films.
- the flexible pocket 1 of the 3D type has, for a fully deployed / filled state that corresponds to the parallelepiped configuration:
- spikes are formed at each of the opposite ends 14 and 15.
- each of the end faces W1 and W2 shown in FIG. 2 has a junction portion 25, 26 projecting from particular more outwardly protruding than any protruding band that can be defined in the relevant face W1 or W2 by a weld between a bellows January 1, 12 and a wall member 2, 3.
- the oblique welds SO1 supplemented as the case may be by a central weld portion CB in the junction portion 25, which makes it possible to shape the junction portion 25 projecting axially (by prolonging the weld zone) while forming the intersection between four protruding bands.
- the welded zones are stiffer than the parts of the non-welded bag, while maintaining a deformable / foldable character that allows at least to fold the flaps 21, 22, 31, 32).
- each salient band defined by the oblique welds SO1, SO2 has:
- connection port or ports 4, 6 may be placed differently, preferably by making the openings on one (preferably only one) of the wall elements 2 and 3.
- the connection port 6 is placed between two flaps 21, 22 of the first wall element 2, away from the side welds SL.
- the flexible bag 1 may have the same general configuration with different connection ports, for example to define a container of the flanged type and allowing agitation, as described in document EP 2 326 412 (see in particular FIGS. 1E at 1 o'clock and Figure 2 in this document). Then we find the wall element 2 which is typically placed on the top and supports the flange (the reverse can be provided with the wall element 2 on the bottom). We notes that, also when the flexible bag 1 allows stirring / mixing applications, the connection port or ports are placed at a distance from the welds, on at least one of the wall elements 2, 3.
- the junction between the flaps 21, 31 and 22, 32 results from a local heating during a sufficiently long exposure period (which may be of the order of a few seconds or possibly 10 seconds for example) to heat or heating by a low voltage electrical pulse (for example up to 9 pulses), thanks to a welding head.
- a low voltage electrical pulse for example up to 9 pulses
- the technique of heating by a low voltage electric pulse can be used so that the aesthetics of the visible face is unchanged while ensuring a good quality of welding: indeed, it does not require high pressure at the time of welding.
- Impulse welding, thermal welding or laser welding techniques can be used to obtain resistant SL, SOI, S02 welds.
- the step 50 of supplying and disposing of the four films 102, 103, 111 and 112 is typically permitted by the use of rollers (not shown) which reel these films in the same general direction, called the longitudinal direction scrolling.
- this direction perpendicular to the sectional sections illustrated to the right of Figure 3, simply serves as a reference for explaining the drawings and it is, of course, possible to route the films with one or more changes of direction (no need that the direction of transport corresponds to a rectilinear layout).
- an exemplary embodiment of the lateral welds SL which are formed in a longitudinal direction (direction or longitudinal direction which can correspond to the direction of travel of the film strips) during the production of the flexible bags 1 can be seen 1
- the insertion of bellows 11 and 12 can be carried out in a manner known per se (see Figure 3 step 50 for supplying and disposing of films 102, 103, 11 1 and 1 12, and the inward folding step 51 of the films 1 1 1, 1 12 for forming the bellows January 1, 12).
- the corresponding film 1 1 1, 1 12 can be held in abutment against a guide used for folding or against an equivalent stop element 40 (FIG. 5).
- the four lateral welds SL can be produced simultaneously during a welding step 52 which makes it possible to assemble the four films 102 and 103 (first pair of films facing each other). -screw), 11 1 and 1 12 (second pair of films vis-à-vis and conveyed transversely relative to the first pair of films).
- the fold lines FL1 and FL2 are kept apart during this welding step 52 so as to define the final transversal spacing D2 between the first bellows 11 and the second bellows 12 in the plane configuration.
- the length of the weld may be longer than the final length of the lateral welds SL, especially in the options that allow oblique cuts.
- the pair of films 102 and 103 makes it possible, after a cutting step 53, to form rectangular sheets 2 ', 3' from which the respective wall elements 2 and 3 can be obtained.
- FIGS. bellows 11 ', 12' which are not yet cut obliquely and which may be of the same length (in the running direction) as the length L1 of the rectangular sheets 2 ', 3'.
- Step 53 of cutting can be optional.
- the material of the four films 102, 103, 1 1 1, 1 12 is here identical. More generally, it will be understood that the first wall element 2, the second wall element 3, the first bellows 11 and the second bellows 12 are defined by rectangular sheets optionally having the same multilayer structure, with a layer defining an internal face adapted for contact with a biopharmaceutical fluid 7.
- the V-shaped cutout makes it possible to define sections of the respective lateral edges 8, 9, 18, 19 and sections of the longitudinal edges of the bellows 11, 12 which are oblique with respect to the longitudinal axis A of the pocket 1, so that a tip of the V-shaped cut is defined only by the first wall member 2 and the second wall member 3 (only two film layers) in an intermediate zone.
- FIGS. 1A, 1B and 4 show that this intermediate zone lies, in the planar empty configuration, between a first virtual straight line coinciding with the longitudinal fold line FL1 of the first bellows 11 and a second virtual straight line coinciding with the longitudinal fold line FL2 of the second bellows 12.
- the pair of films 1 1 1 and 12 folded thus made it possible to form the first bellows 1 and the second bellows 12, and it remains only to complete the welds on both sides of the lateral welds SL.
- the respective lateral edges 8, 9, 18, 19 are each broken down into a first rectilinear section, a second section and a rectilinear intermediate section extending between the first section serving to make an oblique welding SOI and the second section.
- the rectilinear intermediate section is here welded before the other sections to make one of the lateral welds SL.
- the second section may be omitted, for example if it is desired to produce a transverse straight weld of the same width as the films 102, 103 rather than oblique welds S02.
- the respective lateral edges 8, 9, 18, 19 define, by the respective intermediate sections, four straight edges of the flexible bag 1 which are parallel to each other in both the planar configuration and the substantially parallelepipedal configuration, while the portions of the first sections not welded to the first and second bellows January 1, 12 delimit two sides, of identical length, of the joining portion 25. It can be seen in Figure 2 that the first section 8a of the side edge 8, as all the other first sections, breaks down into:
- end portions of the second sections not welded to the bellows January 1, 12 delimit two sides of identical length of the joining portion 26.
- a first substep 56 may make it possible to perform the first oblique welds SOI, here by carrying out two successive welds with a straight bar or with a weld made by a V-shaped welding device which may possibly be more or less curved and more or less expanded in the area of connecting the two branches of the welding device corresponding to the joining portion 25. It may be preferred to locally increase the welding area for the connection between the lateral edges 8, 9, 18, 19 of the wall elements 2 and 3, as shown in Figure 7.
- a second sub-step 57 may make it possible to perform the second oblique welds S02, similarly to the sub-step 56.
- it may be preferred to locally increase the weld zone for the connection between the lateral edges 8, 9, 18, 19 of the wall elements 2 and 3, in the joining portion 26.
- V-shaped cut could alternatively be made only on the side of one of the ends 14, 15.
- a pair of solder bars SB1 or similar elements of a welding unit bear from the outside (against the abutment element 40) on the side edges 8, 9, 18, 19 of the wall elements 2 and 3 and make it possible in particular to perform the lateral welds SL, here by thermal conduction for a short time (also known as pulse welding).
- the duration of conductive heating may be less than or equal to 4 or 6 s, given the high temperature and typically greater than 150 ° C, preferably not exceeding 200 ° C for the upper threshold of effective temperature range of the bars of SB1 welding. It is thus possible to perform the welding step 52 by continuously welding all or part of the longitudinal edges of the bellows 11 and 12 against the lateral edges 8, 18, 9, 19.
- this type of method is applicable to perform oblique welds, for example during the step of producing the seal 55, the welding bars or equivalent members to allow to weld in a straight line being only arranged obliquely .
- each of these welds may be at least equal to 5 mm in order to minimize the risk of leakage by an accidental shock.
- a weld area (corresponding for example to the portion CB) having at least the same extension in width or equivalent diameter greater than 5 mm.
- the weld area in the joining portion 15, for example greater than 4 or 5 cm 2 preferably has a continuous portion entirely offset axially with respect to the bellows January 1, 12 and extending from one to the other. other edges 25a, 25b.
- the thickness of each of the films 102, 103, 111 and 112 is not reduced with respect to the thickness E of the films in the areas away from the welds, the thickness E of these films 102, 103, January 1 and 1 12 being typically constant.
- the welds SL, SOI, SO2 (and in particular in the joining portion 25, 26), there is no frangible zone or other weakened region to allow opening.
- the thickness E is a constant thickness or possibly an average thickness, and can be between 90 and 450 ⁇ for each of these films 102, 103, 111 and 112.
- the flexible pouch 1 is closed hermetically on its four sides when it is in the planar configuration, access to the inside of the pouch 1 being only allowed by the connection ports 4, 6 which are formed in a subsequent step (which can vary the position and / or size of the connection ports 4, 6, depending on the desired biopharmaceutical application for the pocket).
- a filling of the flexible pouch 1 of the 3D type can only be performed after the complete sealing of the flexible pouch 1 and, preferably, the formation of the connection port or ports 4, 6.
- the sealing system or systems C1, C2 can be associated, from the design, to the connection ports 4, 6, in order to prevent any entry of air into the flexible bag 1.
- the flexible bag 1 can be proposed empty, without any orifice allowing the ambient air to enter or, alternatively, systematically with connection ports which form an inlet for biopharmaceutical fluid and an outlet (placed on the same side as the inlet) for the air. This is particularly advantageous for maintaining a biopharmaceutical fluid 7 in a sterile state.
- the flexible pouches 1 of 3D type shown in Figures 2 and 9 allow such maintenance in a sterile state.
- the two opposite ends 14, 15 are designed identically.
- the flexible pouch 1 has a single joining portion on the side of the face W1, which is for example a lower face, while the other end 15 has another type of weld (for example a weld in K) for forming the opposite face W2, upper.
- weld for example a weld in K
- the distance between the opposite ends 14, 15 is typically a length L1 (length common to the wall elements 2, 3 but not to the bellows 1, 12) which exceeds the width L3 defined by the two elements of FIG. wall 2 and 3.
- L1 length common to the wall elements 2, 3 but not to the bellows 1, 12
- D2 denotes a transverse spacing (minimum distance) between the first bellows 11 and the second bellows 12, measured in the transverse direction (same direction as for measuring the width L3).
- the flexible pocket 1 of the 3D type is its robustness, in particular in the ends of the bellows January 1, 12 which are reinforced. Indeed, the induced fragilities due to the more or less precise positioning of the welds at the junctions between the side weld and the corner welds that must be perfectly opposite the folds of the bellows to obtain a perfect K weld (the least fragile possible) are removed.
- the flexible pouch 1 is obtained by a method which limits the number of welding and cutting steps at the ends 14, 15.
- the flexible pouch 1 may optionally have an opening, for example a large upper opening, located on the opposite side to the joining portion 25 or 26, especially for applications where it is necessary to introduce and then mix an additional component in the biopharmaceutical fluid.
Landscapes
- Health & Medical Sciences (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Bag Frames (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1670709A FR3059229B1 (en) | 2016-11-25 | 2016-11-25 | 3D POCKET FOR EMPLOYING BIOPHARMACEUTICAL FLUIDS, AND METHOD FOR MAKING SUCH A POCKET |
PCT/FR2017/000216 WO2018096226A1 (en) | 2016-11-25 | 2017-11-22 | Fillable 3d flexible pouch for biopharmaceutical fluids, and method for producing such a pouch |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3544569A1 true EP3544569A1 (en) | 2019-10-02 |
EP3544569B1 EP3544569B1 (en) | 2020-09-09 |
Family
ID=58162916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17822359.0A Active EP3544569B1 (en) | 2016-11-25 | 2017-11-22 | Fillable 3d flexible pouch for biopharmaceutical fluids, and method for producing such a pouch |
Country Status (5)
Country | Link |
---|---|
US (1) | US11110032B2 (en) |
EP (1) | EP3544569B1 (en) |
CN (1) | CN109982678B (en) |
FR (1) | FR3059229B1 (en) |
WO (1) | WO2018096226A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2017365285B8 (en) * | 2016-11-23 | 2020-04-30 | F. Hoffmann-La Roche Ag | Reservoir for storing a liquid medicament and method of producing a reservoir |
CN113226943B (en) * | 2018-12-26 | 2024-02-13 | 恩特格里斯公司 | Liner for overpack assembly |
CN113291605A (en) * | 2021-06-04 | 2021-08-24 | 泉州国利包装有限公司 | Flexible container |
WO2023076584A1 (en) * | 2021-10-29 | 2023-05-04 | Global Life Sciences Solutions Usa Llc | Apparatus and method for forming a bioprocessing bag |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2074436T3 (en) | 1988-02-04 | 1995-09-16 | Sonoco Ltd | DEVICE AND METHOD TO FACILITATE THE FILLING AND DEPLOYMENT OF A BAG INSIDE AN EXTERNAL BOX. |
DE9207558U1 (en) * | 1992-06-04 | 1992-10-29 | Imer, Rodney Haydn, Dipl.-Ing., 4000 Düsseldorf | Packaging bags for liquid, pasty and granular substances |
TW367297B (en) * | 1994-11-18 | 1999-08-21 | Hosokawa Yoko Kk | Bag for bag-in-box and bag-in-box |
JPH11222244A (en) * | 1998-02-02 | 1999-08-17 | Hosokawa Yoko:Kk | Pharmaceutical and medical gusset bag |
US6090065A (en) * | 1998-07-06 | 2000-07-18 | Evenflo Company, Inc. | Self-cycling breast pump |
FR2781202B1 (en) | 1998-07-16 | 2001-01-12 | Stedim Sa | POCKETS FOR BIO-PHARMACEUTICAL FLUID PRODUCTS |
AU2001236030A1 (en) * | 2000-03-01 | 2001-09-12 | Fujimori Kogyo Co. Ltd. | Inner bag for bag-in-box |
US6371646B1 (en) * | 2000-07-26 | 2002-04-16 | Scholle Custom Packaging, Inc. | Bulk bag with multiple ply walls and a method of forming it from tubular blanks |
US6659132B2 (en) * | 2001-03-19 | 2003-12-09 | Baxter International Inc. | Gas permeable sterile closure |
US6527445B2 (en) * | 2001-05-02 | 2003-03-04 | Scholle Corporation | Liners or bags and method of making them |
NL1021401C2 (en) * | 2002-09-05 | 2004-03-08 | Smq Group B V | Foldable bag. |
CN1654282A (en) * | 2004-02-11 | 2005-08-17 | 巴克斯特国际公司 | Big capacity flexible container |
US7244064B2 (en) * | 2004-04-06 | 2007-07-17 | Cdf Corporation | Bag with flap for bag-in-box container system |
US7798711B2 (en) * | 2004-07-27 | 2010-09-21 | Cdf Corporation | Flexible liner for FIBC or bag-in-box container systems |
DE102004039482B4 (en) * | 2004-08-14 | 2007-04-12 | Protechna S.A. | Liquid container made of plastic |
US8075188B2 (en) * | 2006-02-24 | 2011-12-13 | Cdf Corporation | Flexible liner for FIBC or bag-in-box container systems with improved flex crack resistance |
US8182152B2 (en) * | 2006-03-28 | 2012-05-22 | Cdf Corporation | Flexible liner for FIBC or bag-in-box container systems with improved tensile strength |
US20080310766A1 (en) * | 2007-06-13 | 2008-12-18 | James Plunkett | Liner with bladder |
FR2933881B1 (en) | 2008-07-16 | 2011-05-27 | Sartorius Stedim Biotech Sa | MIXING IN A CONTAINER OF A CONTENT HAVING A BASE COMPONENT AND A MIXING COMPONENT |
US8806843B2 (en) * | 2008-08-26 | 2014-08-19 | S-Pouch Pak Co., Ltd. | Self-standing bag with foldable flange |
ATE512172T1 (en) | 2009-04-07 | 2011-06-15 | Nanogate Ind Solutions Gmbh | IMPRESSION COMPOSITION |
NL2005355C2 (en) * | 2010-09-15 | 2012-03-19 | Gambo Material Handling B V | Bag, in particular for bag-in-box packaging. |
FR3017122B1 (en) * | 2014-02-06 | 2016-02-26 | Sartorius Stedim Fmt Sas | METHOD FOR LOADING A FLEXIBLE 3D POCKET TO BE EMPLOYED, A SYSTEM FOR LOADING AND STORING THIS FLEXIBLE POCKET AND ASSOCIATED SUPPORT DEVICE |
US10046870B2 (en) * | 2014-04-22 | 2018-08-14 | Ge Healthcare Bio-Sciences Corp. | Flexible bag |
FR3053586A1 (en) * | 2016-07-08 | 2018-01-12 | Sartorius Stedim Fmt Sas | 3D POCKET FOR EMPLOYING BIOPHARMACEUTICAL FLUIDS, AND METHOD FOR MAKING SUCH A POCKET |
-
2016
- 2016-11-25 FR FR1670709A patent/FR3059229B1/en not_active Expired - Fee Related
-
2017
- 2017-11-22 US US16/344,910 patent/US11110032B2/en active Active
- 2017-11-22 WO PCT/FR2017/000216 patent/WO2018096226A1/en unknown
- 2017-11-22 CN CN201780070716.0A patent/CN109982678B/en active Active
- 2017-11-22 EP EP17822359.0A patent/EP3544569B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN109982678B (en) | 2021-09-21 |
CN109982678A (en) | 2019-07-05 |
WO2018096226A9 (en) | 2019-06-20 |
FR3059229B1 (en) | 2018-11-16 |
US20190274923A1 (en) | 2019-09-12 |
WO2018096226A1 (en) | 2018-05-31 |
EP3544569B1 (en) | 2020-09-09 |
FR3059229A1 (en) | 2018-06-01 |
US11110032B2 (en) | 2021-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3481737B1 (en) | 3-d flexible bag to be filled for biopharmaceutical fluids and method for creating such a bag | |
EP3544569B1 (en) | Fillable 3d flexible pouch for biopharmaceutical fluids, and method for producing such a pouch | |
CA2956406C (en) | Pouch comprising a safety valve | |
EP0746507B1 (en) | Sealed envelope, particularly tubular bag, method for the manufacture thereof, and method for filling said envelope with a beverage | |
EP1808380A1 (en) | Flexible pouch for a liquid and method of manufacturing thereof | |
CH701338A1 (en) | Protection device for discharge valve fitted to bags for the transport and handling liquid or quasi liquid substances. | |
FR2937025A1 (en) | SEALED ENVELOPE FOR TUBE. | |
EP1296876B1 (en) | Package with strip closure system, method for making same | |
CA2936138C (en) | Two-channel dispensing device intended to close a bottle | |
EP1873093B1 (en) | Flexible package for transporting objects in pneumatic conveyer systems | |
EP0948446B1 (en) | Sealed bag and method for making and packaging liquid in said bag | |
EP2351643B1 (en) | Method for manufacturing a flexible container for medical use | |
FR3138654A3 (en) | Packaging bag with gas and/or humidity barrier properties | |
FR2848812A1 (en) | Sachet for containing livestock artificial insemination has insert made from inner fold in continuous film layer for convenient opening | |
FR2966133A1 (en) | FLEXIBLE CONTAINER FOR LIQUID, PROCESS FOR MANUFACTURING AND FILLING. | |
FR3071155A1 (en) | INTEGRATION OF ACTIVE MATERIAL TO A CONTAINER | |
FR2983181A1 (en) | Sachet for separately storing e.g. dye and oxidant, has compartments including flexible sheets having composite structures made of different materials, where each compartment is closed on peripheral side by closing zone | |
EP1808383A1 (en) | Closing device for a packaging for storage under relative vacuum | |
WO2017125650A1 (en) | Reinforced packaging having two chambers, method for opening and method for manufacturing same | |
EP1972569A1 (en) | Packaging bag comprising closing/opening means, closing/opening means and method of manufacturing packaging bags | |
FR2855453A1 (en) | METHOD AND MACHINE FOR MANUFACTURING A PACKAGING POUCH AND POUCH OBTAINED THEREBY | |
BE617014A (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20190618 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20200618 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1310657 Country of ref document: AT Kind code of ref document: T Effective date: 20200915 Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: FRENCH |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602017023500 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201210 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201209 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201209 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1310657 Country of ref document: AT Kind code of ref document: T Effective date: 20200909 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20200909 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210111 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210109 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602017023500 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201122 |
|
26N | No opposition filed |
Effective date: 20210610 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201130 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201122 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200909 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200923 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230526 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20231123 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20231124 Year of fee payment: 7 Ref country code: DE Payment date: 20231120 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20231121 Year of fee payment: 7 |